BACKGROUND Survivors of childhood malignancies have an increased risk of developing
second malignant neoplasms (SMN) due to their prior treatment and/or genetic …

BACKGROUND Previous studies have shown that children who are treated for soft tissue
sarcoma (STS) are at increased risk for developing second cancers. However, the risk for …

Soft tissue sarcomas (STS) account for approximately 7% of malignant neoplasms in
children. The heterogeneity of STS makes the diagnosis and therapy particularly difficult and …

Purpose: To evaluate the disease-free and overall survival of pediatric patients with
nonrhabdomyosarcoma soft-tissue sarcomas. Methods: We retrospectively analyzed the …

A comment on this article appears in" Specification on the definition of adult-type soft tissue
sarcoma." J Clin Oncol. 2006 Aug 20; 24 (24): 4042-3; author reply 4043-4. This is a …

Currently, approximately 67% of children diagnosed with cancer can be expected to survive
more than 5 years. Among the most significant late effects of cancer therapy is the …

Nonembryonal soft tissue sarcomas are rare in childhood. We report our experience from a
series of 28 patients treated at this centre, whose treatment was based on primary surgical …

Background The objectives of this study were to compare vincristine/actinomycin
D/cyclophosphamide/adriamycin (VACA) with VACA plus imidazole carboxamide …

Purpose The extremity site is a peculiar location for soft-tissue sarcomas (STS) of children
and adolescents. Here we report the experience of the Pediatric Oncology Unit of the Istituto …

This review summarizes and comments on the major articles that have been published in
English concerning pediatric soft-tissue sarcomas in the past 2 years. Studies of …